Trademarkia Logo

Canada

C$
ALPHATHERA
SEARCHED

on 9 Apr 2025

Last Applicant/ Owned by

AlphaThera, Inc.

3401 Grays Ferry AvenuePennovation Center Building 450Philadelphia, PA 19146-2701

US

Serial Number

2213893 filed on 5th Oct 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

ALPHATHERA

Trademark usage description

reagents for scientific and research use; antibodies for scientific and research use; chemicals for scientific and research use; diagnostic reagents f Read More

Classification Information


Class [001]
Reagents for scientific and research use; antibodies for scientific and research use; chemicals for scientific and research use; diagnostic reagents for scientific and research use


Classification kind code

11

Class [005]
Medical diagnostic preparations, materials, reagents, and assays; antibodies


Classification kind code

11

Class [042]
Research and development for scientific and medical research purposes; scientific laboratory services for scientific and medical research purposes; scientific and technological services and research and design relating thereto for scientific and medical research purposes; providing information relating to reagents, antibodies, and chemicals for scientific and medical research purposes; providing scientific and medical research information on immune response and protocols relating to antibody use; providing scientific information on the selection, production, purification, application, structure and activities of antibodies; providing technical support relating to reagent, antibody, and chemical selection and use, namely, providing technical consultation services


Classification kind code

11

Mark Details


Serial Number

2213893

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 9th Apr 2025
Search Recorded
Submitted for opposition 20
on 9th Apr 2025
Examiner's First Report
Submitted for opposition 287
on 13th Oct 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 5th Oct 2022
Filed
Submitted for opposition 1
on 5th Oct 2022
Created
Submitted for opposition 31
on 5th Oct 2022
Formalized